RecruitingPhase 4NCT04921943
Hypertonic Saline for MAC
Studying OBSOLETE: Mycobacterium xenopi infection
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Intervention
- Hypertonic saline(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2025
Study locations (3)
- NYU Langone Health, New York, New York, United States
- Oregon Health & Science University, Portland, Oregon, United States
- University Health Network, Toronto, Ontario, Canada
Collaborators
NTM Info & Research, Inc. · University Health Network, Toronto · New York University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04921943 on ClinicalTrials.govOther trials for OBSOLETE: Mycobacterium xenopi infection
Additional recruiting or active studies for the same condition.
See all trials for OBSOLETE: Mycobacterium xenopi infection →